A New Paradigm for Developing Antiviral Drugs Exemplified by the Development of Supremely High Anti-Hiv Active EFdA

Journal of Antivirals & Antiretrovirals
doi 10.4172/jaa.1000092
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Development of a Vaginal Delivery Film Containing EFdA, a Novel Anti-Hiv Nucleoside Reverse Transcriptase Inhibitor

International Journal of Pharmaceutics
Pharmaceutical Science
2014English

The Curious Stories of Drugs With Two Lives: A New Paradigm in Drug Development

Journal of the Royal Society of Medicine
Medicine
2015English

Developing New Drugs

Veterinary Record
MedicineVeterinary
2014English

The Development of a New Validated HPLC and Spectrophotometric Methods for the Simultaneous Determination of Daclatasvir and Sofosbuvir: Antiviral Drugs

Journal of Pharmacy and Pharmacology Research
2017English

Tutorial Teaching: A New Paradigm for the Development of Competencies

Journal of Educational, Cultural and Psychological Studies
DevelopmentalEducationEducational PsychologySocial Psychology
2013English

HCV/HIV Coinfection: A New Treatment Paradigm

Gastroenterology
HepatologyGastroenterology
2015English

The High Genetic Barrier of EFdA/MK-8591 Stems From Strong Interactions With the Active Site of Drug-Resistant HIV-1 Reverse Transcriptase

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2018English

Orthopoxvirus Targets for the Development of New Antiviral Agents

Antiviral Research
VirologyPharmacology
2012English

Development of HIV Vectors for Anti-Hiv Gene Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy